Norgine Revenue and Competitors

Amsterdam, Netherlands

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Norgine's estimated annual revenue is currently $237.8M per year.(i)
  • Norgine's estimated revenue per employee is $201,000

Employee Data

  • Norgine has 1183 Employees.(i)
  • Norgine grew their employee count by -1% last year.

Norgine's People

NameTitleEmail/Phone
1
Associate Director Product Owner Enabling FunctionsReveal Email/Phone
2
Chief Medical OfficerReveal Email/Phone
3
Chief Manufacturing OfficerReveal Email/Phone
4
Interim CFOReveal Email/Phone
5
Chief Operating OfficerReveal Email/Phone
6
VPReveal Email/Phone
7
Chief Legal OfficerReveal Email/Phone
8
Chief Corporate Development OfficerReveal Email/Phone
9
Quality OfficerReveal Email/Phone
10
VP, Head CommunicationsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$13.9M69-1%N/AN/A
#2
$43.8M218-13%N/AN/A
#3
$51.9M2584%N/AN/A
#4
$32.2M1600%N/AN/A
#5
$237.8M1183-1%N/AN/A
#6
$3.8M1946%N/AN/A
#7
$237.8M1183-1%N/AN/A
#8
$20.1M100-31%N/AN/A
#9
$75M373-8%N/AN/A
#10
$2M1025%N/AN/A
Add Company

What Is Norgine?

Norgine is a leading European specialist pharmaceutical company that has been bringing transformative medicines to patients for over a century. Our commitment to transforming people's lives drives everything we do and our European experience, fully integrated infrastructure and exceptional partnership approach enables us to quickly apply creative solutions to bring life-changing medicines to patients that they may not otherwise be able to access. Norgine is proud to have helped 22 million patients around the world in 2019 and generated €419 million in net product sales, a growth of 6% over 2018. Norgine has a direct presence in 12 European countries, as well as Australia and New Zealand. We also have a strong global network of partnerships in non-Norgine markets. We are a flexible and fully integrated pharmaceutical business, with manufacturing (Hengoed, Wales and Dreux, France), third party supply networks and significant product development capabilities, in addition to our sales and marketing infrastructure. This enables us to acquire, develop and commercialise specialist and innovative products that make a real difference to the lives of patients around the world. In 2012, Norgine established Norgine Ventures, a complementary business which supports innovative healthcare companies through the provision of debt-like financing in Europe and the US. For more information, please visit www.norgineventures.com.

keywords:N/A

N/A

Total Funding

1183

Number of Employees

$237.8M

Revenue (est)

-1%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Norgine News

2022-04-20 - Oral Mucositis Drugs Market Size, Outlook And Forecast | 3M ...

3M Healthcare, GSK, Pfizer, Colgate-Palmolive, Norgine, Sobi, Bausch Health, EUSA Pharma, Camurus, Clinigen Group, 3M Healthcare, Alliance Pharma.

2022-04-17 - Oral Mucositis Drugs for Cancer Therapy Market Analysis ...

Key players – 3M Healthcare, GSK, Pfizer, Colgate-Palmolive, Norgine, Sobi, Bausch Health, EUSA Pharma, Camurus, Clinigen Group,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$237.8M1183-1%N/A
#2
$35M121471%N/A
#3
$259.4M1278-4%N/A
#4
$15M12857%N/A
#5
$411.8M14353%N/A